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Abstract
Purpose To evaluate the pregnancy rate (PR) of unstim-
ulated intrauterine insemination (IUI).
Methods This was a retrospective study in a private fer-
tility clinic. Between 2004 and 2013, a total of 4,045
women underwent 17,830 cycles of unstimulated IUI. The
etiologies of subfertility in the couples were unexplained
(51 %), male factor (36 %), coital problems (9.5 %), and
cervical factor (3.5 %).
Results The PRs/cycle, between the 1st and 9th trials, in
women \35, 35–37, 38–40, 41–42, and [42 years of age
were 8.2, 7.3, 5.5, 3.6, and 0.9 %, respectively. In 10,076
cycles in which the male partner had a total motile sperm
count C5 million, the PRs in the respective age groups
were 9.9, 8.6, 6.1, 4.8, and 1.2 %. The largest-sized
reported PRs for clomiphene citrate (CC)/IUI in the
respective age groups were 11.5, 9.2, 7.3 4.3, and 1.0 %
(4,199 cycles in total, Dovey et al., FertilSteril,
2008;90:2281–2286). There were no significant differences
in PRs between unstimulated IUI and CC/IUI.
Conclusion PR for unstimulated IUI was similar to the
reported PR for CC/IUI. Although this was a retrospective
study without a control group, to reduce multiple preg-
nancy rate, we believe that unstimulated IUI is a reasonable
treatment.
Keywords Controlled ovarian hyperstimulation 
Intrauterine insemination  Multiple pregnancy  Pregnancy
rate  Unstimulated
Introduction
Intrauterine insemination (IUI) is a common treatment for
cervical factor, male factor, coital problems, and unex-
plained subfertility. In a previous review, the pregnancy
rate (PR) per cycle for unexplained subfertility was
reported to be 1.3–4.1 % with expectant management,
3.8 % with unstimulated IUI, 5.6 % with clomiphene cit-
rate (CC), 8.3 % with CC/IUI, 7.7 % with gonadotropin
(GT) administration, 17.1 % with GT/IUI, and 20.7 % with
assisted reproductive technology (ART) [1]. With regard to
male factor subfertility, PR of GT/IUI is superior to that of
unstimulated IUI [2, 3]. Consequently, IUI has been per-
formed generally combined with controlled ovarian
hyperstimulation (COH), i.e., with CC and/or GT. The
European Society of Human Reproduction and Embryol-
ogy (ESHRE) Capri Workshop Group reported that PR was
12.4 % in 98,388 cycles of IUI performed in 2004, and that
the incidence of multiple births with IUI was 11.8 %,
suggesting that most cycles were combined with COH [4].
Since a potential complication of COH/IUI is the increased
risk of multiple pregnancies, it was regarded as question-
able whether Grade-A evidence for the efficacy of COH/
IUI exists [5]. In addition, van Rumste et al., reported that,
in COH/IUI, monofollicular growth is ideal, bifollicular
growth is acceptable, but growth of [ 2 follicles does not
increase PR substantially but increases the multiple preg-
nancy rate (MPR) [6].
In Japan, as well as worldwide, multiple pregnancies
due to subfertility treatment including ART rapidly
increased in the 1990s, resulting in a heavy treatment
burden in the field of perinatal and neonatal medicine. In
2008, the Japan Society of Obstetrics and Gynecology
(JSOG) established a guideline that single embryo transfer
(SET) should be done, that double ET could be permitted
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only in some conditions, and that [ 2 embryos cannot be
transferred in any conditions [7]. Since then, SET has
prevailed in Japan, and in 2011, 75 % (118,179/158,101) of
ETs were performed as SETs. In addition, the ratio of
ART-induced multiple pregnancies per ART pregnancies
has decreased to 4.2 % [8]. Unfortunately, there are no
systematic statistics on the outcomes resulting from non-
ART in Japan, and the JSOG is planning a survey for
multiple births resulting from ovulation induction with
non-ART [9]. Although the precise percentage has not yet
been made clear, we speculate that multiple pregnancies
from non-ART treatments represent the majority of those
resulting from subfertility treatments currently in Japan,
especially for high-order multiples, and that the physicians
should make an effort to decrease multiple pregnancies
resulting from non-ART.
Our institution is a private fertility clinic in Tokyo,
Japan. Until 2005, for women with ovulatory cycles and
unexplained subfertility, we performed 4 cycles of
unstimulated IUI, followed by 2 cycles of COH/IUI, and
then ART. Since 2006, we have generally discontinued the
use of COH/IUI for ovulatory women to decrease the
incidence of multiple pregnancies. In the present study, to
investigate the efficacy of unstimulated IUI, we analyzed
17,830 cycles of unstimulated IUI. Although retrospective,




For subfertile women with ovulatory cycles and without
absolute indication of ART (bilateral tubal obstruction or
severe male factor subfertility), if they are aged B37 years,
we propose 6 cycles of timed intercourse (TI), followed by
6 cycles of IUI, and then ART. For women aged C 38
years, we propose 3 cycles of TI, followed by 3 cycles of
IUI, and then ART. Ultimately, however, the final decision
regarding the number of cycles of TI and/or IUI performed
is made by the couple. Because oocyte donation is not
permitted in Japan, we do not limit the upper age for
women undergoing IUI. Donor insemination is not per-
formed in our clinic.
Participants and ethical aspects
We retrospectively analyzed 17,830 cycles of 4,045 women
who underwent unstimulated IUI between January 2004 and
December 2013.The etiologies of the couples were unex-
plained (51 %), mild to moderate male factor (36 %), coital
problems (erectile disorder, ejaculatory disorder, or
dyspareunia; 9.5 %) and cervical factor (3.5 %). Mean age
of treated women was 36.6 ± 3.7 years (mean ± SD),
ranging from 23 to 52 years. We categorized the women’s
age as \ 35 (1,292 women, 4,443 cycles), 35–37 (1,219
women, 4,794 cycles), 38–40 (999 women, 4,634 cycles),
41–42 (344 women, 2,111 cycles), and [ 42 years (191
women, 1,848 cycles). A written informed consent was
obtained from each couple. This study was approved by the
ethical committee of Japanese Institution for Standardizing
Assisted Reproductive Technology(JISART).
Timing of IUI
To determine the timing of IUI, patients visited our clinic a
few days before the estimated ovulation and underwent an
ultrasonography scan and assessment of urinary luteinizing
hormone (LH) using an assay kit. When a follicle with a
diameter of[ 18 mm was detected and the urinary LH was
positive, IUI was performed the next day.We did not use
human chorionic gonadotropin as ovulation trigger routinely.
Sperm preparation
Sperm was prepared by density-gradient centrifugation
using Sil-Select Plus (Ferti Pro N.V., Beemem, Belgium).
The volume of the final suspension of motile sperm was
0.5 mL and insemination was performed using a Kitazato
IUI catheter (Kitazato Corporation, Tokyo, Japan).
Luteal support
Luteal support was not performed routinely but performed
only for women whose mid-luteal progesterone
was \ 10 ng/mL in the previous cycle. For luteal support,
we administered 4 mg/day of chlormadinone acetate (Lu-
toral, Shionogi Pharmaceutical Co., Osaka, Japan) for
10 days immediately after ovulation.
Outcomes
‘‘Pregnancy’’ was defined as clinical pregnancies, includ-
ing an intrauterine pregnancies in which a gestational sac
was confirmed on ultrasonography, and ectopic pregnan-
cies that required surgical/medical intervention. Biochem-
ical pregnancies were not included in ‘‘pregnancy.’’ ‘‘Live
birth’’ includes live births and ongoing pregnancies after
11 weeks. Stillbirths were not included in ‘‘live birth.’’
Statistics
For statistical analysis, we used a Chi square for indepen-
dence test. The difference was considered significant at
P \ 0.5.
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Results
PR and live birth rate (LBR) per trial in each age group are
shown in Fig. 1. The mean PR and LBR per cycle between
the 1st and 9th trials were 8.2 and 6.9 % in women
at \ 35 years (Fig. 1a), 7.3 and 5.9 % at 35–37 years
(Fig. 1b), 5.5 and 3.9 % at 38–40 years (Fig. 1c), 3.6 and
2.1 % at 41–42 years (Fig. 1d), and 0.9 and 0.3 %
at [42 years (Fig. 1e), respectively.The rate of multiple
birth per live birth was 0.6 % (5/780) and all cases were
twin pregnancies.
To investigate the relation between PR and the trial
number, we compared the PR in the 1st to 3rd, 4th to 6th,
and 7th to 9th trials (Fig. 2). The PRs were higher in the first
3 cycles, at \35 years (Fig. 2a), at 35–37 years (Fig. 2b),
and at 38–40 years (Fig. 2c), but the PRs were not different
at 41–42 years (Fig. 2d), and at [42 years (Fig. 2e). The
PR in the 4th to 6th trials and that in the 7th to 9th trials were
not significantly different in each age group.
The cumulative LBR in each age group is shown in
Fig. 3a. The ratio of cumulative LBR in the first 3 cycles
per cumulative LBR in the total cycles was 73.6, 74.3, and
66.7 % in at \35 years, at 35–37 years, and at
38–40 years, respectively. The numbers of patients in each
trial by age group are shown in Fig. 3b. There were no
patients aged \35 years who underwent [15 cycles.
Our primary aim was to compare PR for unstimulated
IUI to that for CC/IUI. Dovey et al., reported a retrospec-
tive analysis of 4,199 cycles of CC/IUI with total motile
sperm count of C5 million [10]. We selected the 10,076
cycles in which the male partner had a total motile sperm
count C 5 million in the final suspension, and we com-
pared our data to theirs (Table 1). The PRs in the each age
group were not significantly different between in our
unstimulated IUI and in their CC/IUI.
Discussion
As described in the Introduction, the reduction of multiple
pregnancies resulting from COH/TI to COH/IUI is specu-
lated to be an important matter currently in Japan. In a
review, the twin PR and high-order multiple PR are
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Fig. 1 Pregnancy rate (PR) and
live birth rate (LBR) per trial
cycle in women at \35 (a),
35–37 (b), 38–40(c), 41–42 (d),
and [42 years of age (e)
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and 0 % for low-dose GT/IUI, and 0–12.5 % and 0–3.7 %
for CC/IUI, respectively [11]. The rate of multiple gesta-
tions for GT/IUI is too high to be accepted currently in
Japan. The twin PR for CC/IUI is rather acceptable, but
high-order multiple pregnancies are a problem.
To avoid iatrogenic multiple pregnancies, we performed
unstimulated IUI for ovulatory women since 2006 and
present a retrospective analysis in this report. Our primary
aim was to compare PR for unstimulated IUI to that for CC/
IUI. The reported PR per cycle for CC/IUI varies from 2.0 to
19.3 % [11], but the reviewed reports included relatively
small sample sizes. Dovey et al., reported a retrospective
analysis of 4,199 cycles of CC/IUI with total motile sperm
count of C 5 million [10], and we compared our data to
theirs (Table 1). The PR/cycle was not significantly different
between in our unstimulated IUI and in their CC/IUI. In
addition, oligo-anovulatory women were included in their
CC/IUI. There is a report that PR with CC/IUI is higher in
anovulatory women than in ovulatory women [12]. There-
fore, we consider that PR in our unstimulated IUI was similar
to those in their CC/IUI. In a review in 1998, PR with
unstimulated IUI was reported to be 3.8 % [1]. This could
have been an underestimation. We showed a higher PR with
unstimulated IUI in this study. This is probably because
fertility clinics are easily accessible in Tokyo, and the
patients were able to visit us frequently if necessary, and the
appropriate timing of IUI was determined.
Our second aim was to investigate how many cycles of
IUI should be attempted. Dovey et al., reported that
because the overwhelming majority of pregnancies occur
within 3–4 cycles, there seems to be little benefit to con-
tinue beyond this [10]. In contrast, Custers et al., reported
that PR after the 6th cycle is acceptable [13]. In this study,
we showed that PR in the 1st to 3rd trials was higher than
that in the 4th to 6th trials in women at \ 41 years. Does
this suggest that we should recommend the younger women
to proceed to ART after the 3rd IUI? However, the ratio of
cumulative LBR in the first 3 cycles per cumulative LBR in
the total cycles was 67–74 % at \41 years, and; therefore,
about 30 % of women were able to have a baby after the
3rd trial. Thus, we consider that the IUI trial after the 3rd is
not useless. This issue must be clarified by a randomized
controlled study, considering the cost-effectiveness,
because ART has more cost and risk than IUI does. On the
other hand, the PR in the 4th to 6th trials and that in the 7th
to 9th trials were not significantly different in any age
group. So, it seems reasonable to continue IUI after 6th
cycle, if the couples request IUI but not ART.
(A) <35 years (B) 35–37 years

















































Fig. 2 The relation between pregnancy rate (PR) and the number of
trial cycle in women at \ 35 (a), 35–37 (b), 38–40 (c), 41–42 (d),






























Fig. 3 a Cumulative live birth rate (LBR) and b the number of
patients in each trial by age group
30 Reprod Med Biol (2015) 14:27–32
123
Medico-social circumstances are different among
nations. For reference, the multiple delivery rate per ET
was 19.2 % in Europe in 2010 [14]. In the US, the rate of
multiple births per all live births resulting from fresh ET
from nondonor eggs in women aged \ 35 years was 32 %,
and that from frozen embryos in women aged \ 35 years
was 25 % in 2011 [15]. The guidelines for MPRs can vary
among nations, and those in other nations would likely not
to apply in Japan. Thus, they are not presented in this
report. The main conclusion of the present study is that PR
in unstimulated IUI is acceptable in the context of strong
social needs to decrease iatrogenic multiple births in Japan.
In conclusion, we believe that unstimulated IUI has been
underestimated and is a reasonable choice of antecedent
treatment to ART.
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